Pages that link to "Q43979001"
Jump to navigation
Jump to search
The following pages link to Type 2 diabetes care: the role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention (Q43979001):
Displaying 11 items.
- Rosiglitazone (Q33684266) (← links)
- The natural history of type 2 diabetes. Implications for clinical practice (Q33752751) (← links)
- Remodeling adipose tissue through in silico modulation of fat storage for the prevention of type 2 diabetes. (Q33791444) (← links)
- Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes (Q33844872) (← links)
- Understanding the metabolic syndrome: a modeling perspective (Q34129723) (← links)
- Are all glitazones the same? (Q34580975) (← links)
- Tuning the electrical properties of the heart by differential trafficking of KATP ion channel complexes (Q37733013) (← links)
- Up-regulation of aldolase A and methylglyoxal production in adipocytes (Q39210197) (← links)
- The cardiovascular dysmetabolic syndrome. (Q54128061) (← links)
- Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model (Q86701386) (← links)
- Abstracts of the 6th International Congress of the Immunology of Diabetes Society and American Diabetes Association Research Symposium. October 3-6, 2002, Copper Mountain, Colorado, USA (Q95790217) (← links)